SGOC yields 32.26% · PFE yields 6.13%● Live data
📍 SGOC pulled ahead of the other in Year 1
Combined, SGOC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SGOC + PFE for your $10,000?
SGOCO Group Ltd. is a holding company, which engages in environmental protection, energy saving technologies, equipment development and applications, money lending business in Hong Kong providing mortgage loans to high quality target borrowers and property investment to generate additional rental income. The company employs 8 full-time employees The firm is focused on developing its own-brands and distributing its branded products in the Chinese flat-panel display market. The firm's main products are liquid crystal display (LCD)/light emitting diode (LED) monitors, All-in-One (AIO) and Part-in-One (PIO) computers and other application-specific products. The firm's product lines include LCD/LED monitors with screen sizes of approximately 40 inches and application-specific LCD/LED display products, such as tablet personal computers (PCs) for commercial and consumer use, all-in-one e-reader notebooks, cell phone devices, mobile Internet devices, e-boards that integrate software and hardware functionalities, rotating screens, closed-circuit television (CCTV) monitors for security systems, billboard monitors for advertising and public notice systems, as well as touch screens for non-keyed entries. The company offers LCD/LED products under various brands, such as SGOCO, No. 10 and POVIZON.
Full SGOC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.